Journal of Radiation Protection and Research

  • 제48권1호
  • /
  • Pages.1-8
  • /
  • 2023
  • /
  • 2508-1888(pISSN)
  • /
  • 2466-2461(eISSN)
대한방사선방어학회 (The Korean Association for Radiation Protection)
권호 표지
DOI QR코드

DOI QR Code

Effects of Vitamin E Derivative TMG on the Radiation Protector and Tumor Growth during Radiotherapy

  • Yeun-Hwa Gu (Department of Radiological Science, Graduate School of Health Science, Junshin Gakuen University) ;
  • Ryo Matsumoto (Department of Radiological Science, Graduate School of Health Science, Junshin Gakuen University) ;
  • Takenori Yamashita (Department of Radiological Science, Faculty of Health Science, Suzuka University of Medical Science)
  • 투고 : 2021.04.16
  • 심사 : 2022.03.08
  • 발행 : 2023.03.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Background: The purpose of this study is to evaluate the immunosuppressive and antioxidant effects of a novel radioprotective agent using the vitamin E derivative 2-(alpha-D-glucopyranosyl)methyl-2,5,7,8-tetramethylchroman-6-ol (TMG) and its effect on tumors, and to study its usefulness. Materials and Methods: In this study, C57BL/6NCrSlc mice were divided into four groups (control, TMG, radiation therapy [RT], and RT+TMG), using 10 mice in each group. In the TMG and 2 Gy+TMG groups, 500 mg/kg TMG was administered. Two groups (2 Gy and 2 Gy+TMG) among RT and RT+TMG groups were irradiated with 2 Gy in a single fraction, while the other two groups (6 Gy and 6 Gy+TMG) were irradiated locally with 6 Gy in three fractions. Results and Discussion: TMG positively affected CD4+ and CD8+ T lymphocytes. Tumor volumes and growth inhibition rates were compared. In order to evaluate how TMG administration affected tumor growth, Ehrlich cancer cells were injected into the thigh of mice, and the tumor volume and growth suppression rate were compared. Not only RT but also TMG alone inhibited tumor growth. If RT conducted to the mice with TMG, TMG could increase the number of leukocytes, primarily that of lymphocytes. TMG also inhibited tumor growth in addition to RT. Tumor growth was significantly inhibited in the 6 Gy+TMG group. Conclusion: In conclusion, TMG exerted an immunopotentiating effect mainly by increasing the white blood cell numbers including that of lymphocytes. In addition to RT, TMG also inhibited tumor growth. Therefore, TMG is considered to be a useful radioprotective agent in radiotherapy without tumor growth induction.

키워드

참고문헌

  1. Bortfeld T, Jeraj R. The physical basis and future of radiation therapy. Br J Radiol. 2011;84(1002):485-498. https://doi.org/10.1259/bjr/86221320
  2. Citrin D, Cotrim AP, Hyodo F, Baum BJ, Krishna MC, Mitchell JB. Radioprotectors and mitigators of radiation-induced normal tissue injury. Oncologist. 2010;15(4):360-371. https://doi.org/10.1634/theoncologist.2009-S104
  3. Bourhis J, Blanchard P, Maillard E, Brizel DM, Movsas B, Buentzel J, et al. Effect of amifostine on survival among patients treated with radiotherapy: a meta-analysis of individual patient data. J Clin Oncol. 2011;29(18):2590-2597. https://doi.org/10.1200/JCO.2010.33.1454
  4. Galluzzi L, Kepp O, Kroemer G. Immunogenic cell death in radiation therapy. Oncoimmunology. 2013;2(10):e26536.
  5. Golden EB, Apetoh L. Radiotherapy and immunogenic cell death. Semin Radiat Oncol. 2015;25(1):11-17. https://doi.org/10.1016/j.semradonc.2014.07.005
  6. Stanton SE, Disis ML. Clinical significance of tumor-infiltrating lymphocytes in breast cancer. J Immunother Cancer. 2016;4(1):59.
  7. Peh HY, Tan WS, Liao W, Wong WS. Vitamin E therapy beyond cancer: tocopherol versus tocotrienol. Pharmacol Ther. 2016;162:152-169. https://doi.org/10.1016/j.pharmthera.2015.12.003
  8. Pekmezci D. Vitamin E and immunity. Vitam Horm. 2011;86:179-215. https://doi.org/10.1016/B978-0-12-386960-9.00008-3
  9. Singh PK, Krishnan S. Vitamin E analogs as radiation response modifiers. Evid Based Complement Alternat Med. 2015;2015:741301.
  10. Crawford J, Dale DC, Lyman GH. Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management. Cancer. 2004;100(2):228-237. https://doi.org/10.1002/cncr.11882
  11. Grossman SA, Ellsworth S, Campian J, Wild AT, Herman JM, Laheru D, et al. Survival in patients with severe lymphopenia following treatment with radiation and chemotherapy for newly diagnosed solid tumors. J Natl Compr Canc Netw. 2015;13(10):1225-1231. https://doi.org/10.6004/jnccn.2015.0151
  12. Sun J, Chen X, Gao P, Song Y, Huang X, Yang Y, et al. Can the neutrophil to lymphocyte ratio be used to determine gastric cancer treatment outcomes?: a systematic review and meta-analysis. Dis Markers. 2016;2016:7862469.
  13. Tang L, Li X, Wang B, Luo G, Gu L, Chen L, et al. Prognostic value of neutrophil-to-lymphocyte ratio in localized and advanced prostate cancer: a systematic review and meta-analysis. PLoS One. 2016;11(4):e0153981.
  14. Yang JJ, Hu ZG, Shi WX, Deng T, He SQ, Yuan SG. Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a meta-analysis. World J Gastroenterol. 2015;21(9):2807-2815. https://doi.org/10.3748/wjg.v21.i9.2807
  15. Nakamura N, Kusunoki Y, Akiyama M. Radiosensitivity of CD4 or CD8 positive human T-lymphocytes by an in vitro colony formation assay. Radiat Res. 1990;123(2):224-227. https://doi.org/10.2307/3577549
  16. Johnke RM, Sattler JA, Allison RR. Radioprotective agents for radiation therapy: future trends. Future Oncol. 2014;10(15):2345-2357. https://doi.org/10.2217/fon.14.175
  17. Wasserman TH, Brizel DM, Henke M, Monnier A, Eschwege F, Sauer R, et al. Influence of intravenous amifostine on xerostomia, tumor control, and survival after radiotherapy for head-and- neck cancer: 2-year follow-up of a prospective, randomized, phase III trial. Int J Radiat Oncol Biol Phys. 2005;63(4):985-990. https://doi.org/10.1016/j.ijrobp.2005.07.966
  18. Clark IA. How TNF was recognized as a key mechanism of disease. Cytokine Growth Factor Rev. 2007;18(3-4):335-343. https://doi.org/10.1016/j.cytogfr.2007.04.002
  19. Zidi I, Mestiri S, Bartegi A, Amor NB. TNF-alpha and its inhibitors in cancer. Med Oncol. 2010;27(2):185-198. https://doi.org/10.1007/s12032-009-9190-3
  20. Gu YH, Takagi Y, Nakamura T, Hasegawa T, Suzuki I, Oshima M, et al. Enhancement of radioprotection and anti-tumor immunity by yeast-derived beta-glucan in mice. J Med Food. 2005;8(2):154-158. https://doi.org/10.1089/jmf.2005.8.154
  21. Yamashita T, Kato T, Isogai T, Gu Y, Ma N. Protective effects of taurine on the radiation exposure induced cellular damages in the mouse intestine. Adv Exp Med Biol. 2019;1155:443-450. https://doi.org/10.1007/978-981-13-8023-5_41
  22. Gu YH, Yamashita T, Matsuo T, Washino N, Song JH, Kang KM, et al. Improve the intestinal bacterial flora environment on renal function recovery in chronic kidney disease by efficacy of administration of plant enzymes. Asian J Complement Altern Med. 2020;8(1):9-16.
  23. Guo W, Xie Z, Cai L, Liu G, Deng L, Mei W, et al. Synthesis of purine analogues: photocatalyst-free visible-light-enhanced annulation approach to pyrazolo[1,5-a][1,3,5]triazine-2,4-diamines. J Org Chem. 2021;86(12):8365-8380. https://doi.org/10.1021/acs.joc.1c00783
  24. Bhadra M, Transue WJ, Lim H, Cowley RE, Lee JYC, Siegler MA, et al. A thioether-ligated cupric superoxide model with hydrogen atom abstraction reactivity. J Am Chem Soc. 2021;143(10):3707-3713. https://doi.org/10.1021/jacs.1c00260
  25. Svobodova Kovarikova A, Stixova L, Kovarik A, Komurkova D, Legartova S, Fagherazzi P, et al. N6-adenosine methylation in RNA and a reduced m3G/TMG level in non-coding RNAs appear at microirradiation-induced DNA lesions. Cells. 2020;9(2):360.